Event chart ASTELLAS PHARMA INC. |
|
|
Upcoming events on ASTELLAS PHARMA INC. |
|
02/06/23 | 01:00am | | Q3 2022 Earnings Release |
02/06/23 | 01:30am | | Q3 2022 Earnings Call |
02/17/23 | | Investor Meeting - Sustainability Meeting |
03/30/23 | | Ex-dividend day for final dividend |
04/27/23 | | FY 2022 Earnings Release (Projected) |
07/28/23 | | Q1 2023 Earnings Release (Projected) |
11/02/23 | | Interim 2023 Earnings Release (Projected) |
01/31/24 | | Q3 2023 Earnings Release (Projected) |
|
Past events on ASTELLAS PHARMA INC. |
|
01/22/23 | 07:30pm | | zolbetuximab Update Call |
01/19/23 | 04:30pm | | American Society of Clinical Oncology Gastrointestinal Cancers Symposium - Abstract - LBA292 |
12/08/22 | 08:00pm | | R&D Day |
10/31/22 | 03:00am | | Interim 2022 Earnings Call |
10/31/22 | | Interim 2022 Earnings Release |
10/16/22 | 08:30pm | | Analyst Meeting - Fezolinetant |
10/14/22 | 04:45pm | | North american spine society meeting - abstract numnber: s-24 |
10/13/22 | 06:15pm | | North american spine society meeting - abstract numnber: p-16 |
10/13/22 | 06:15pm | | North american spine society meeting - abstract numnber: p-53 |
10/13/22 | 06:15pm | | North american spine society meeting - abstract numnber: p-74 |
|
Past dividends on ASTELLAS PHARMA INC. |
|
09/29/22 | | Interim Payment 30 JPY |
03/30/22 | | Final Payment 25 JPY |
09/29/21 | | Interim Payment 25 JPY |
03/30/21 | | Final Payment 21 JPY |
09/29/20 | | Interim Payment 21 JPY |
03/30/20 | | Final Payment 20 JPY |
09/27/19 | | Interim Payment 20 JPY |
03/27/19 | | Final Payment 19 JPY |
09/26/18 | | Interim Payment 19 JPY |
03/28/18 | | Final Payment 18 JPY |
|
|
Fiscal Period : March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
Sales M JPY |
Released Forecast Spread | 1 300 316 1 295 193 0,40% | 1 306 348 1 300 930 0,42% | 1 300 843 1 274 827 2,0% | 1 249 528 1 258 841 -0,74% | 1 296 163 1 320 041 -1,8% | 1 495 776 |
Operating income (EBITDA) M JPY |
Released Forecast Spread | 278 121 287 331 -3,2% | 307 370 320 763 -4,2% | 310 387 316 993 -2,1% | 208 703 300 597 -31% | 235 370 316 919 -26% | 365 550 |
Operating profit (EBIT) M JPY |
Released Forecast Spread | 213 258 228 416 -6,6% | 243 912 261 093 -6,6% | 243 991 257 148 -5,1% | 136 051 221 342 -39% | 155 686 219 051 -29% | 269 317 |
Pre-Tax Profit (EBT) M JPY |
Released Forecast Spread | 218 113 230 652 -5,4% | 248 967 259 605 -4,1% | 245 350 262 926 -6,7% | 145 324 219 749 -34% | 156 886 214 703 -27% | 262 791 |
Net income M JPY |
Released Forecast Spread | 164 679 178 600 -7,8% | 222 265 215 115 3,3% | 195 411 203 519 -4,0% | 120 589 176 431 -32% | 124 086 177 294 -30% | 208 171 |
EPS JPY |
Released Forecast Spread | 81,1 89,5 -9,4% | 115 113 1,6% | 104 113 -7,8% | 64,9 96,5 -33% | 67,1 94,2 -29% | 114 | Announcement Date | 04/26/2018 | 04/25/2019 | 05/14/2020 | 04/27/2021 | 04/27/2022 | - |
|
|
Fiscal Period : March | 2019 S1 | 2019 S2 | 2020 S1 | 2021 Q2 | 2021 S1 | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 S1 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 S1 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 S1 |
Sales M JPY |
Released Forecast Spread | 647 096 646 500 0,09% |
| 650 470 630 717 3,1% | 308 511 317 330 -2,8% | 615 480 631 150 -2,5% | 325 427 322 842 0,80% | 308 621 315 922 -2,3% | 326 143 317 725 2,6% | 325 523 333 552 -2,4% | 651 666 653 900 -0,34% | 340 627 350 400 -2,8% | 303 870 324 327 -6,3% | 381 791 345 350 11% | 380 394 360 355 5,6% | 762 185 748 000 1,9% | 395 900 | 357 358 | 373 000 | 756 000 |
Operating profit (EBIT) M JPY |
Released Forecast Spread | 126 842 131 500 -3,5% |
| 162 196 135 036 20% | 26 057 69 070 -62% | 86 872 139 408 -38% | 72 598 67 332 7,8% | -23 419 55 665 -142% | 36 090 57 475 -37% | 54 079 71 237 -24% | 90 169 138 200 -35% | 79 202 73 625 7,6% | -13 685 41 432 -133% | 33 147 47 625 -30% | 86 744 75 977 14% | 119 891 117 500 2,0% | 83 350 | 66 405 | 55 500 | 135 500 |
Pre-Tax Profit (EBT) M |
Released Forecast Spread | 128 298
|
| 161 584 134 807 20% | 28 853 69 236 -58% | 89 091 139 808 -36% | 75 136 67 337 12% | -18 903 57 000 -133% | 35 830 66 200 -46% | 53 255 75 500 -29% | 89 085 143 200 -38% | 78 317 71 700 9,2% | -10 516 41 300 -125% | 31 679 48 800 -35% | 88 801 95 700 -7,2% | 120 480 115 500 4,3% | 78 000 | 86 100 | 55 400 | 136 500 |
Net income M JPY |
Released Forecast Spread | 103 867 106 000 -2,0% |
| 128 527 105 652 22% | 22 425 54 652 -59% | 72 838 110 808 -34% | 60 079 53 195 13% | -12 328 44 500 -128% | 30 687 52 250 -41% | 40 922 58 900 -31% | 71 609 113 700 -37% | 60 886 55 900 8,9% | -8 409 32 500 -126% | 24 812 35 300 -30% | 71 622 74 600 -4,0% | 96 434 90 000 7,1% | 60 800 | 67 200 | 43 200 | 106 500 |
EPS
|
Released Forecast Spread | 53,2 51,1 4,1% | 61,9
| 68,2 57,4 19% | 12,1 27,3 -56% | 39,2 54,5 -28% | 32,4 30,1 7,4% | -6,63 23,0 -129% | 16,6 23,9 -31% | 22,1 30,3 -27% | 38,7 61,4 -37% | 32,9 32,1 2,4% | -4,43 15,9 -128% | 13,6 18,6 -27% | 39,3 33,6 17% | 52,9 46,6 13% | 39,2 | 25,7 | 20,0 | 56,8 | Announcement Date | 10/31/2018 | 04/25/2019 | 10/31/2019 | 10/30/2020 | 10/30/2020 | 01/29/2021 | 04/27/2021 | 07/30/2021 | 10/29/2021 | 10/29/2021 | 02/02/2022 | 04/27/2022 | 08/01/2022 | 10/31/2022 | 10/31/2022 | - | - | - | - | |
|
|
Upcoming sector events for ASTELLAS PHARMA INC. |
|
|
|
Past sector events for ASTELLAS PHARMA INC. |
|
|
|
|
|
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise
|